Cargando…
Resultados en la práctica asistencial y coste marginal del tratamiento con tocilizumab en pacientes COVID-19
OBJECTIVE: To describe the marginal cost and survival of patients treated with tocilizumab in a university hospital under real-life conditions and to evaluate factors that could influence costs and health outcomes will be evaluated. METHODS: Observational, single-center, retrospective study of a coh...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750892/ https://www.ncbi.nlm.nih.gov/pubmed/36635189 http://dx.doi.org/10.1016/j.farma.2022.12.003 |